House

Eshallgo Inc Secures $5 Million through Convertible Debenture Offering

SHANGHAI,Dec. 2,2024-- Eshallgo Inc ("Eshallgo" or the "Company") (NasdaqCM: EHGO),one of the leading office solution providers in China,today announced that it has entered into a

12-04

Wexler Announces $1.4 Million Pre-Seed Financing, Global Law Firm Adoption and Launch of AI Agent to Enhance Dispute Resolution

Top Global Law Firms Explore Wexler to Streamline Document Review in Litigation for Their Most Complex Cases

12-04

Samsung Biologics hosts ESG event with suppliers to strengthen decarbonization efforts

INCHEON,South Korea,Dec. 3,2024-- Samsung Biologics (KRX: 207940.KS),a global contract development and manufacturing organization (CDMO),today hosted its second Supplier ESG Day to share insights on

12-04

Rongsheng Petrochemical Upholds 'Green' Principles as MSCI ESG Rating Rises to BBB

HANGZHOU,China,Dec. 4,2024-- A news report from:Shenzhen Panorama Network Last week,MSCI,a globally leading index provider,has announced its latest ESG ratings for 2024. Rongsheng Petrochemical (00249

12-04

Two Stations, One Mission: Uniting Art and Conservation in a Continuing Journey

《ART FOR THE EARTH: An Exhibition for Conservation》 HONG KONG,Dec. 4,2024-- Building on the success of "ART FOR THE EARTH: An Exhibition and Auction for Conservation",an initiative spearhe

12-04

Innovent and HUTCHMED Jointly Announce NMPA Conditional Approval for TYVYT® (Sintilimab Injection) in Combination with ELUNATE® (Fruquintinib) for the Treatment of Advanced Endometrial Cancer

SAN FRANCISCO,U.S. andSUZHOU,China,Dec. 4,2024-- Innovent Biologics,Inc. ("Innovent") (HKEX: 01801),a world-class biopharmaceutical company that develops,manufactures and commercializes high

12-04

CNOOC Limited Brings On-stream Huizhou 26-6 Oilfield Development Project

HONG KONG,Dec. 2,2024-- CNOOC Limited (the "Company",SEHK: 00883 (HKD Counter) and 80883 (RMB Counter),SSE: 600938) today announces that Huizhou 26-6 Oilfield Development Project has commen

12-02

Longbridge Securities has fully upgraded its "Take-Profit and Stop-Loss" feature, offering more flexible risk management to help you secure your gains with ease!

HONG KONG,Dec. 2,2024-- Market volatility has significantly increased,fueling investors\' demand for risk management tools. To address this need for better risk control in stock investing,a new-genera

12-02

Jingle All the Way: Agoda Shares Five Christmas Markets in Asia

SINGAPORE,Dec. 2,2024-- Ever wonder where Santa gets his inspiration from? Digital travel platform Agoda shares five enchanting Christmas markets across Asia where Santa might just be spotted this ho

12-02

The DJI Power Expansion Battery 2000 Confidently Extends Power For All Situations

The Compact Expansion Battery Offers Rapid Charging to Power Your Home and the Great Outdoors SHENZHEN,China,Nov. 29,2024--DJI,the global leader in civilian drones and camera technology,today officia

11-30

Home Previous 67 68 69 70 71 72 73 Next Tail

10 Items Per Page (Page 70 / 96) Total 960 Items

Newest

1Cangxi County Holds 2026 New Year's Cultural Performance for the Public

Cangxi County Holds 2026 New Year's Cultural Performance for the Public

2The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

3The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

4Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange

Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange

5Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference

Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference

6Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement

Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement

©copyright 2009-2020 Singapore Info Map